DNA News and Research

RSS

DNA, or deoxyribonucleic acid, is the hereditary material in humans and almost all other organisms. Nearly every cell in a person’s body has the same DNA. Most DNA is located in the cell nucleus (where it is called nuclear DNA), but a small amount of DNA can also be found in the mitochondria (where it is called mitochondrial DNA or mtDNA).

Investigational drug ameliorates neuronal DNA damage and inflammation in Alzheimer's model

Accumulation of DNA damage in the brain's neurons may contribute to the development of Alzheimer's disease.

8 Jul 2026

Bio-Rad launches Vericheck ddPCR Kits compatible with QX700 platform for biopharma quality control and cell and gene therapy workflows

Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, today announced the launch of the QX700 System-compatible Vericheck ddPCR Kit portfolio for critical quality control (QC) workflows in advanced cell and gene therapy development and other biopharma applications.

From Bio-Rad Laboratories 8 Jul 2026

Study uncovers genetic clues behind sex differences in Parkinson's disease

New research presented today (Wednesday) at the Federation of European Neuroscience Societies (FENS) Forum 2026 has discovered some of the genetic changes in brain cells that may help to explain why more men than women develop Parkinson's disease.

7 Jul 2026

Eppendorf focuses outreach programs to advance STEM education in Europe

Eppendorf, a leading international life science company that develops, manufactures, and distributes instruments, consumables, and services for use in laboratories around the world, today highlights its European outreach activities dedicated to addressing persistent challenges in STEM education.

From Eppendorf 7 Jul 2026

New EV-SELEX strategy accelerates drug discovery for wide range of GPCRs

G protein-coupled receptors (GPCRs) are the most abundantly expressed proteins in the human body, which regulate diverse physiological processes ranging from pain perception to hormone signaling.

7 Jul 2026

Countable Labs and Promega announce co-marketing agreement to facilitate end-to end biological sample preparation and rare variant detection

Countable Labs, the developer of Countable PCR, a breakthrough single-molecule PCR technology redefining how science measures biology, announced a co-marketing agreement with Promega, a leader in providing innovative solutions and technical support to the life sciences industry.

From Promega Corporation 7 Jul 2026

Air pollution may impact genes involved in sperm development

New research presented today at the 42nd Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE) suggests that exposure to air pollution may impact genes associated with sperm development, raising new questions about male fertility, pregnancy outcomes and offspring health.

6 Jul 2026

Memory B cells reveal how nasal vaccines could stop respiratory infections earlier

A Science Immunology Review explains how memory B cells acquire diverse molecular, epigenetic, and tissue-specific programs that shape long-term immune protection. It highlights lung-resident memory B cells as a key target for mucosal vaccines, potentially improving control of airborne infections and reducing transmission.

6 Jul 2026

New method helps scientists better understand DNA organization

Researchers from the Cancer Science Institute of Singapore (CSI Singapore) at NUS have developed a new method that allows scientists to better understand how DNA is organized and regulated inside our cells.

6 Jul 2026

New study highlights noninvasive biomarkers for colorectal cancer detection

Emerging discoveries in liquid biomarker research promise to transform early detection, diagnosis, and treatment monitoring of colorectal cancer (CRC), according to a new study, offering less invasive alternatives to traditional methods that often require surgical interventions or tissue biopsies.

6 Jul 2026

Targeted therapy shows promise against KRAS-driven metastatic pancreatic cancer

An investigational targeted therapy designed to block one of the most common genetic drivers of pancreatic cancer has shown promising early results when combined with standard first-line chemotherapy, according to research presented today at the ESMO Gastrointestinal Cancers Congress 2026.

3 Jul 2026

Blood test may predict which colorectal cancer patients benefit from chemotherapy

A blood test may help identify which patients with colorectal cancer that has spread to the liver are most likely to benefit from chemotherapy after surgery, according to research presented today at the ESMO Gastrointestinal Cancers Congress 2026.

3 Jul 2026

Cat fleas may contribute to murine typhus transmission in Texas

As human cases of flea-borne murine typhus continue to occur in South Texas, researchers are working to better understand the role cats and their fleas may play in the disease's transmission cycle.

2 Jul 2026

Prenatal high fructose exposure impairs brain development and memory

Nutritional imbalance during pregnancy can have long-lasting effects on the health status and disease susceptibility of the offspring.

2 Jul 2026

New testing approach improves pulmonary fibrosis diagnosis and treatment

A new Mayo Clinic study shows that integrating telomere length evaluation and genetic testing into pulmonary care can significantly change how physicians diagnose and treat pulmonary fibrosis - in some cases even redirecting the course of care.

2 Jul 2026

New genome editing tool unlocks fungi's hidden drug-producing potential

Researchers have spent decades-and billions of dollars-sequencing animal and crop genomes, but fungi have historically been the forgotten middle child of genomics, only noticed when they're ruining bread or colonizing toes.

2 Jul 2026

Targeted therapy doubles progression-free survival in rare bile duct cancer

Results of the ongoing eNRGy trial, a single-arm, multicenter, global phase 2 clinical trial evaluating zenocutuzumab in solid tumors positive for Neuregulin 1 (NRG1) gene fusions, reported manageable side effects and clinically meaningful efficacy – including a near doubling of progression-free survival compared to expectations with standard of care – in previously treated patients with advanced NRG1-positive cholangiocarcinoma.

2 Jul 2026

Evolutionary noncoding RNAs reveal new targets for cancer therapy

In cancer research, one person's junk is increasingly becoming another person's treasure. Scientists have now uncovered new evidence showing how recently evolved "junk DNA" genetic elements can become integrated into ancient cellular pathways that regulate cancer.

1 Jul 2026

KFF poll finds vaccine myths reach many Americans but convince few

KFF’s 2026 tracking poll found that many U.S. adults have heard common vaccine myths, including false claims about MMR, COVID-19, mRNA vaccines, and measles vaccines. Fewer adults strongly believe these myths, but a large, uncertain “malleable middle” remains, especially among those without a trusted health care provider, frequent social media users, some AI health-information users, and parents who delayed or skipped childhood vaccines.

1 Jul 2026

Study potential new therapeutic strategy for patients with ATRX-mutant gliomas

A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common genetic alterations in glioma rewires the cancer cell genome to fuel tumor progression, suggesting a potential new therapeutic strategy for patients with ATRX-mutant gliomas.

1 Jul 2026